chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Mobility decreased
Clinical narrative: I began experiencing pain in both hips (approximately a 6 on 10 point scale)/as well as both shoulders; Making it difficult to rise from a chair and sleep without knees elevated; This is a spontaneous report from a contactable consumer (patient). A 72-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 29Mar2021 09:30 (Batch/Lot Number: ER8733) (age at vaccination) as DOSE 2, SINGLE for covid-19 immunisation in hospital. Relevant medical history and concurrent conditions included high cholesterol, acute sleep apnea (using CPAP), Continuous positive airway pressure and allergies to Penicillin. Historical vaccine included BNT162B2 at 08Mar2021 10:00 AM as dose number 1 (Batch/Lot number: EN6206 and Anatomical Location: Arm Left) for covid-19 immunisation and experienced yellow bruise the size of a $.50 piece manifested at injection site (vaccination site bruising). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took minocin and bactrim and experienced drug hypersensitivity. The patient received other medications within 2 weeks of vaccination. On 02Apr2021, the patient experienced i began experiencing pain in both hips (approximately a 6 on 10-point scale)/as well as both shoulders and making it difficult to rise from a chair and sleep without knees elevated. The patient received the initial Pfizer COVID-19 vaccination, LOT #EN6206, on 08Mar2021 at 09:55 am. About three days later a yellow bruise the size of a withheld piece manifested at injection site in upper left arm. Disappeared within one week. No other manifestations. On 29Mar2021 at 09:30 am, I received the second COVID-19 vaccine LOT #ER8733 injection in upper left arm. Approximately 72 hours later I began experiencing pain in both hips (approximately a 6 on 10-point scale), making it difficult to rise from a chair and sleep without knees elevated, as well as both shoulders. Pain has reduced to Level 2-3 in hips, and Level 1 in shoulders. Pain has persisted thru this writing on 07Apr2021 at 2:30 pm. The patient did not received treatment for the events. The outcome of the event Mobility decreased was resolving whereas another event was not resolved.  No follow up attempts needed. No further information expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angioedema, Condition aggravated, Urticaria
Clinical narrative: Hives on stomach and legs; This is a spontaneous report from a contactable consumer, the patient. A 37-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown) via an unspecified route of administration in the arm left on 17Mar2021, (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic idiopathic urticaria. The patient had known allergies to penicillin. Concomitant medication included Omalizumab (XOLAIR) (MANUFACTURER UNKNOWN) injection on 25Mar2021 for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the right arm on 24Feb2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 06:00 the patient experienced hives on stomach and legs which started 18 hours after 2nd shot and still currently have the hives 2 weeks later. The patient took unspecified medications as a therapeutic measure for adverse event. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event hives on stomach and legs was not recovered.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: deleted second dosage regimen for Xolair, updated vaccine administration anatomical site in narrative.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Hives on stomach and legs; This is a spontaneous report from a contactable consumer, the patient. A 37-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown) via an unspecified route of administration in the arm left on 17Mar2021, (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic idiopathic urticaria. The patient had known allergies to penicillin. Concomitant medication included Omalizumab (XOLAIR) (MANUFACTURER UNKNOWN) injection on 25Mar2021 for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the right arm on 24Feb2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 06:00 the patient experienced hives on stomach and legs which started 18 hours after 2nd shot and still currently have the hives 2 weeks later. The patient took unspecified medications as a therapeutic measure for adverse event. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event hives on stomach and legs was not recovered.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: deleted second dosage regimen for Xolair, updated vaccine administration anatomical site in narrative.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood pressure measurement, Dizziness, Heart rate, Heart rate decreased
Clinical narrative: injection error, weak legs, dizziness, headache, 190/105 120 pulse
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Hypertension, Muscular weakness, Pain in extremity, Palpitations
Clinical narrative: injection error, weak legs, dizziness, headache, 190/105 120 pulse
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Muscular weakness, Syringe issue
Clinical narrative: injection error, weak legs, dizziness, headache, 190/105 120 pulse
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood test, Catheterisation cardiac, Chest X-ray, Computerised tomogram thorax
Clinical narrative: Extreme fatigue at slightest exertion; weakness; shortness of breath; nausea; dizziness; confusion; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 18Apr2021 13:30 (Lot Number: ER8735, at age of 59 years old) as single dose for COVID-19 immunisation. Medical history included Diabetes 2, hypertension, hypothyroidism, essential tremors. The patient previously received first dose of bnt162b2 (lot number=ER8734, dose administration time=10:00 AM, vaccine location=Right arm) on 28Mar2021 (at age of 59 years old) for COVID-19 immunisation. Concomitant medications were included unspecified medication. The patient experienced extreme fatigue at slightest exertion, weakness, shortness of breath, nausea, dizziness, confusion on 19Apr2021. Events resulted in: Doctor or other healthcare professional office/clinic visit. The patient received treatment for events: CPAP (continuous positive airway pressure therapy). The patient underwent lab tests and procedures which included covid test Nasal Swab (PCR): negative in 2021. The outcome of events was not recovered.  Follow-up (25Oct2021): Follow-up attempts are completed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Dyspnoea, Echocardiogram, Electrocardiogram, Fatigue
Clinical narrative: Extreme fatigue at slightest exertion; weakness; shortness of breath; nausea; dizziness; confusion; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 18Apr2021 13:30 (Lot Number: ER8735, at age of 59 years old) as single dose for COVID-19 immunisation. Medical history included Diabetes 2, hypertension, hypothyroidism, essential tremors. The patient previously received first dose of bnt162b2 (lot number=ER8734, dose administration time=10:00 AM, vaccine location=Right arm) on 28Mar2021 (at age of 59 years old) for COVID-19 immunisation. Concomitant medications were included unspecified medication. The patient experienced extreme fatigue at slightest exertion, weakness, shortness of breath, nausea, dizziness, confusion on 19Apr2021. Events resulted in: Doctor or other healthcare professional office/clinic visit. The patient received treatment for events: CPAP (continuous positive airway pressure therapy). The patient underwent lab tests and procedures which included covid test Nasal Swab (PCR): negative in 2021. The outcome of events was not recovered.  Follow-up (25Oct2021): Follow-up attempts are completed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary function test, Sleep study
Clinical narrative: Extreme fatigue at slightest exertion; weakness; shortness of breath; nausea; dizziness; confusion; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 18Apr2021 13:30 (Lot Number: ER8735, at age of 59 years old) as single dose for COVID-19 immunisation. Medical history included Diabetes 2, hypertension, hypothyroidism, essential tremors. The patient previously received first dose of bnt162b2 (lot number=ER8734, dose administration time=10:00 AM, vaccine location=Right arm) on 28Mar2021 (at age of 59 years old) for COVID-19 immunisation. Concomitant medications were included unspecified medication. The patient experienced extreme fatigue at slightest exertion, weakness, shortness of breath, nausea, dizziness, confusion on 19Apr2021. Events resulted in: Doctor or other healthcare professional office/clinic visit. The patient received treatment for events: CPAP (continuous positive airway pressure therapy). The patient underwent lab tests and procedures which included covid test Nasal Swab (PCR): negative in 2021. The outcome of events was not recovered.  Follow-up (25Oct2021): Follow-up attempts are completed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Confusional state, Dizziness, Dyspnoea, Fatigue
Clinical narrative: Extreme fatigue at slightest exertion; weakness; shortness of breath; nausea; dizziness; confusion; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 18Apr2021 13:30 (Lot Number: ER8735, at age of 59 years old) as single dose for COVID-19 immunisation. Medical history included Diabetes 2, hypertension, hypothyroidism, essential tremors. The patient previously received first dose of bnt162b2 (lot number=ER8734, dose administration time=10:00 AM, vaccine location=Right arm) on 28Mar2021 (at age of 59 years old) for COVID-19 immunisation. Concomitant medications were included unspecified medication. The patient experienced extreme fatigue at slightest exertion, weakness, shortness of breath, nausea, dizziness, confusion on 19Apr2021. Events resulted in: Doctor or other healthcare professional office/clinic visit. The patient received treatment for events: CPAP (continuous positive airway pressure therapy). The patient underwent lab tests and procedures which included covid test Nasal Swab (PCR): negative in 2021. The outcome of events was not recovered.  Follow-up (25Oct2021): Follow-up attempts are completed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, SARS-CoV-2 test
Clinical narrative: Extreme fatigue at slightest exertion; weakness; shortness of breath; nausea; dizziness; confusion; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 18Apr2021 13:30 (Lot Number: ER8735, at age of 59 years old) as single dose for COVID-19 immunisation. Medical history included Diabetes 2, hypertension, hypothyroidism, essential tremors. The patient previously received first dose of bnt162b2 (lot number=ER8734, dose administration time=10:00 AM, vaccine location=Right arm) on 28Mar2021 (at age of 59 years old) for COVID-19 immunisation. Concomitant medications were included unspecified medication. The patient experienced extreme fatigue at slightest exertion, weakness, shortness of breath, nausea, dizziness, confusion on 19Apr2021. Events resulted in: Doctor or other healthcare professional office/clinic visit. The patient received treatment for events: CPAP (continuous positive airway pressure therapy). The patient underwent lab tests and procedures which included covid test Nasal Swab (PCR): negative in 2021. The outcome of events was not recovered.  Follow-up (25Oct2021): Follow-up attempts are completed. No further information is expected.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested Positive for Covid
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature increased, Face oedema, Nausea, Rash, Syncope
Clinical narrative: Patient experiences hives and pruritis and a feeling of lips and ears swelling.  She describes the rash as burning. She is tachycardic (128 bpm)  BP = 148/88..  All other vitals are within normal limits.  Patient initially saw her PCP, who administered a steroid injection.  She took diphenhydramine and cetirizine at home with no improvement.  In the ER, she is treated with diphenhydramine, famotidine, methylprednisolone x 2, epinephrine x 2.  She improved and was d/c home with prescriptions for Epi pen, steroid dosepak and famotidine.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Patient experiences hives and pruritis and a feeling of lips and ears swelling.  She describes the rash as burning. She is tachycardic (128 bpm)  BP = 148/88..  All other vitals are within normal limits.  Patient initially saw her PCP, who administered a steroid injection.  She took diphenhydramine and cetirizine at home with no improvement.  In the ER, she is treated with diphenhydramine, famotidine, methylprednisolone x 2, epinephrine x 2.  She improved and was d/c home with prescriptions for Epi pen, steroid dosepak and famotidine.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Ear swelling, Lip swelling, Pruritus, Rash
Clinical narrative: Patient experiences hives and pruritis and a feeling of lips and ears swelling.  She describes the rash as burning. She is tachycardic (128 bpm)  BP = 148/88..  All other vitals are within normal limits.  Patient initially saw her PCP, who administered a steroid injection.  She took diphenhydramine and cetirizine at home with no improvement.  In the ER, she is treated with diphenhydramine, famotidine, methylprednisolone x 2, epinephrine x 2.  She improved and was d/c home with prescriptions for Epi pen, steroid dosepak and famotidine.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tachycardia, Urticaria
Clinical narrative: Patient experiences hives and pruritis and a feeling of lips and ears swelling.  She describes the rash as burning. She is tachycardic (128 bpm)  BP = 148/88..  All other vitals are within normal limits.  Patient initially saw her PCP, who administered a steroid injection.  She took diphenhydramine and cetirizine at home with no improvement.  In the ER, she is treated with diphenhydramine, famotidine, methylprednisolone x 2, epinephrine x 2.  She improved and was d/c home with prescriptions for Epi pen, steroid dosepak and famotidine.
Age: 12.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Product administered to patient of inappropriate age
Clinical narrative: Patient received Pfizer as first dose of vaccine and accidentally received Johnson and Johnson as second vaccine dose. Father reports after vaccine immediately was tired, limp and pale with emesis. Since then he has had continued concentration and short term memory difficulties requiring additional assistance in school
Age: 12.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Confusional state, Insomnia, Interchange of vaccine products, Product administered to patient of inappropriate age
Clinical narrative: Patient received Pfizer as first dose of vaccine and accidentally received Johnson and Johnson as second vaccine dose. Father reports after vaccine immediately was tired, limp and pale with emesis. Since then he has had continued concentration and short term memory difficulties requiring additional assistance in school
Age: 12.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Disturbance in attention, Fatigue, Immediate post-injection reaction, Interchange of vaccine products
Clinical narrative: Patient received Pfizer as first dose of vaccine and accidentally received Johnson and Johnson as second vaccine dose. Father reports after vaccine immediately was tired, limp and pale with emesis. Since then he has had continued concentration and short term memory difficulties requiring additional assistance in school
Age: 12.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Loss of personal independence in daily activities, Memory impairment, Pallor, Vomiting
Clinical narrative: Patient received Pfizer as first dose of vaccine and accidentally received Johnson and Johnson as second vaccine dose. Father reports after vaccine immediately was tired, limp and pale with emesis. Since then he has had continued concentration and short term memory difficulties requiring additional assistance in school
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Computerised tomogram, Heart rate increased, Interstitial lung disease, Mobility decreased
Clinical narrative: pneumonia; This is a spontaneous report from a contactable consumer (patient). A 71-years-old non-pregnant female patient received first dose of BNT162B2, via an unspecified route of administration at the age of 71-years-old on 06Feb2021 (Lot Number: EL 9269; Expiration Date: 31May2021) as single dose for covid-19 immunisation. Medical history included diabetes II, arthritis, gastroparesis, hypertension, hyperlipidemia, post hero neur, recent ILD and St 3 CKD. Concomitant medications included nabumetone; VIT D; fexofenadine hydrochloride (ALLEGRA); dexlansoprazole (DEXILANT); allopurinol. The patient first diagnosed with pneumonia 23Feb2021 (subsequent multiple times). Adverse event resulted in doctor or other healthcare professional office/clinic visit and treatment with antibiotic. Covid test post vaccination: covid test type post vaccination(Nasal Swab) on 24May2021, on 18Jun2021 and on 16Aug2021: negative. The outcome of the events was not recovered.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Oxygen saturation decreased, Pneumonia, Pulmonary function test, X-ray
Clinical narrative: pneumonia; This is a spontaneous report from a contactable consumer (patient). A 71-years-old non-pregnant female patient received first dose of BNT162B2, via an unspecified route of administration at the age of 71-years-old on 06Feb2021 (Lot Number: EL 9269; Expiration Date: 31May2021) as single dose for covid-19 immunisation. Medical history included diabetes II, arthritis, gastroparesis, hypertension, hyperlipidemia, post hero neur, recent ILD and St 3 CKD. Concomitant medications included nabumetone; VIT D; fexofenadine hydrochloride (ALLEGRA); dexlansoprazole (DEXILANT); allopurinol. The patient first diagnosed with pneumonia 23Feb2021 (subsequent multiple times). Adverse event resulted in doctor or other healthcare professional office/clinic visit and treatment with antibiotic. Covid test post vaccination: covid test type post vaccination(Nasal Swab) on 24May2021, on 18Jun2021 and on 16Aug2021: negative. The outcome of the events was not recovered.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pneumonia, SARS-CoV-2 test
Clinical narrative: pneumonia; This is a spontaneous report from a contactable consumer (patient). A 71-years-old non-pregnant female patient received first dose of BNT162B2, via an unspecified route of administration at the age of 71-years-old on 06Feb2021 (Lot Number: EL 9269; Expiration Date: 31May2021) as single dose for covid-19 immunisation. Medical history included diabetes II, arthritis, gastroparesis, hypertension, hyperlipidemia, post hero neur, recent ILD and St 3 CKD. Concomitant medications included nabumetone; VIT D; fexofenadine hydrochloride (ALLEGRA); dexlansoprazole (DEXILANT); allopurinol. The patient first diagnosed with pneumonia 23Feb2021 (subsequent multiple times). Adverse event resulted in doctor or other healthcare professional office/clinic visit and treatment with antibiotic. Covid test post vaccination: covid test type post vaccination(Nasal Swab) on 24May2021, on 18Jun2021 and on 16Aug2021: negative. The outcome of the events was not recovered.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia
Clinical narrative: I experienced Jaw pain that went up to her left ear; therefore, she went to Urgent Care and my ears were fine. They were more concerned with the chest pain and sent me the ER (had a chest X-ray, EKG, and some bloodwork). Chest X-ray reveal left and right contusions, EKG showed an abnormal and was referred to a Cardiologist for additional tests. The Cardiologist also noticed that I had inflammation in my chest and that my blood pressure was elevated. My PCP prescribed 500mg Naproxen and 25 mg Hydrochlorothiazide on 10/19/2021 for the symptoms that I experienced and for the chest inflammation. I have a appointment for a Echo Cardiogram and ECG is scheduled on 10/29/2021, Ultrasound will be the end or beginning of the 1 or 2 week in November.  I
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia, Atelectasis, Blood pressure increased, Blood test normal, Chest X-ray abnormal
Clinical narrative: I experienced Jaw pain that went up to her left ear; therefore, she went to Urgent Care and my ears were fine. They were more concerned with the chest pain and sent me the ER (had a chest X-ray, EKG, and some bloodwork). Chest X-ray reveal left and right contusions, EKG showed an abnormal and was referred to a Cardiologist for additional tests. The Cardiologist also noticed that I had inflammation in my chest and that my blood pressure was elevated. My PCP prescribed 500mg Naproxen and 25 mg Hydrochlorothiazide on 10/19/2021 for the symptoms that I experienced and for the chest inflammation. I have a appointment for a Echo Cardiogram and ECG is scheduled on 10/29/2021, Ultrasound will be the end or beginning of the 1 or 2 week in November.  I
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Contusion, Ear pain, Electrocardiogram, Inflammation
Clinical narrative: I experienced Jaw pain that went up to her left ear; therefore, she went to Urgent Care and my ears were fine. They were more concerned with the chest pain and sent me the ER (had a chest X-ray, EKG, and some bloodwork). Chest X-ray reveal left and right contusions, EKG showed an abnormal and was referred to a Cardiologist for additional tests. The Cardiologist also noticed that I had inflammation in my chest and that my blood pressure was elevated. My PCP prescribed 500mg Naproxen and 25 mg Hydrochlorothiazide on 10/19/2021 for the symptoms that I experienced and for the chest inflammation. I have a appointment for a Echo Cardiogram and ECG is scheduled on 10/29/2021, Ultrasound will be the end or beginning of the 1 or 2 week in November.  I
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in jaw, Pleural effusion
Clinical narrative: I experienced Jaw pain that went up to her left ear; therefore, she went to Urgent Care and my ears were fine. They were more concerned with the chest pain and sent me the ER (had a chest X-ray, EKG, and some bloodwork). Chest X-ray reveal left and right contusions, EKG showed an abnormal and was referred to a Cardiologist for additional tests. The Cardiologist also noticed that I had inflammation in my chest and that my blood pressure was elevated. My PCP prescribed 500mg Naproxen and 25 mg Hydrochlorothiazide on 10/19/2021 for the symptoms that I experienced and for the chest inflammation. I have a appointment for a Echo Cardiogram and ECG is scheduled on 10/29/2021, Ultrasound will be the end or beginning of the 1 or 2 week in November.  I
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Extra dose administered, Furuncle
Clinical narrative: I spoke with patient via phone on 10/26/21.  Patient called to inform us that after her COVID vaccine on 10/14/21, she experienced two small rashes on her neck and face the morning after her vaccination.  She treated these with rubbing alcohol and they were resolved.  Further, the patient reported wheezing, breathing problems and a slight fever (98.8) beginning 3-4 days after her vaccination.  Her symptoms have persisted.  She denies COPD, emphysema, and asthma.  I asked her to call her primary care provider and make an appointment.  I will plan on checking on her on Thursday 10/28/21 via phone.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Rash, Wheezing
Clinical narrative: I spoke with patient via phone on 10/26/21.  Patient called to inform us that after her COVID vaccine on 10/14/21, she experienced two small rashes on her neck and face the morning after her vaccination.  She treated these with rubbing alcohol and they were resolved.  Further, the patient reported wheezing, breathing problems and a slight fever (98.8) beginning 3-4 days after her vaccination.  Her symptoms have persisted.  She denies COPD, emphysema, and asthma.  I asked her to call her primary care provider and make an appointment.  I will plan on checking on her on Thursday 10/28/21 via phone.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram ST segment elevation, Myocarditis, Troponin decreased
Clinical narrative: *PCP Office triage note from 10/19/21 at 4pm: Patient was woken up at 4 am with chest pain, mid chest. Now c/o chest tightness, nausea and feels like vomiting- But dry heaving along with bloody nose from dry heaving. Denies SOB, pain traveling into arm, shoulder, ear, jaw, dizziness, cool moist skin, and blue lips. Advise to seek care @ ER- per protocol *Presented to the emergency department of Hospital on 10/19. Discharged 10/20.  Hospital note impression:  "-Acute myopericarditis. Likely referable to to recent booster dose of Moderna vaccine. Expected clinical course would be resolution. Symptomatic treatment with anti-inflammatory agents is reasonable. Declining troponin resolution of chest pain are encouraging for recovery.  -Hypertensive disorder: I suspect the hypertension and tachycardia secondary to the underlying inflammatory condition will resolve. Plan:  1. Metoprolol succinate 25 mg daily: will likely discontinue at follow-up.  2. Ibuprofen 800 mg Q 8 H prn for recurrent chest pain 3. Return to clinic to see me in approximately 2 weeks with an echocardiogram the same day. "
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Echocardiogram normal, Electrocardiogram ST segment elevation, Epistaxis
Clinical narrative: *PCP Office triage note from 10/19/21 at 4pm: Patient was woken up at 4 am with chest pain, mid chest. Now c/o chest tightness, nausea and feels like vomiting- But dry heaving along with bloody nose from dry heaving. Denies SOB, pain traveling into arm, shoulder, ear, jaw, dizziness, cool moist skin, and blue lips. Advise to seek care @ ER- per protocol *Presented to the emergency department of Hospital on 10/19. Discharged 10/20.  Hospital note impression:  "-Acute myopericarditis. Likely referable to to recent booster dose of Moderna vaccine. Expected clinical course would be resolution. Symptomatic treatment with anti-inflammatory agents is reasonable. Declining troponin resolution of chest pain are encouraging for recovery.  -Hypertensive disorder: I suspect the hypertension and tachycardia secondary to the underlying inflammatory condition will resolve. Plan:  1. Metoprolol succinate 25 mg daily: will likely discontinue at follow-up.  2. Ibuprofen 800 mg Q 8 H prn for recurrent chest pain 3. Return to clinic to see me in approximately 2 weeks with an echocardiogram the same day. "
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Extra dose administered, Hypertension, Inflammation, Myocarditis, Nausea
Clinical narrative: *PCP Office triage note from 10/19/21 at 4pm: Patient was woken up at 4 am with chest pain, mid chest. Now c/o chest tightness, nausea and feels like vomiting- But dry heaving along with bloody nose from dry heaving. Denies SOB, pain traveling into arm, shoulder, ear, jaw, dizziness, cool moist skin, and blue lips. Advise to seek care @ ER- per protocol *Presented to the emergency department of Hospital on 10/19. Discharged 10/20.  Hospital note impression:  "-Acute myopericarditis. Likely referable to to recent booster dose of Moderna vaccine. Expected clinical course would be resolution. Symptomatic treatment with anti-inflammatory agents is reasonable. Declining troponin resolution of chest pain are encouraging for recovery.  -Hypertensive disorder: I suspect the hypertension and tachycardia secondary to the underlying inflammatory condition will resolve. Plan:  1. Metoprolol succinate 25 mg daily: will likely discontinue at follow-up.  2. Ibuprofen 800 mg Q 8 H prn for recurrent chest pain 3. Return to clinic to see me in approximately 2 weeks with an echocardiogram the same day. "
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Retching, Sleep disorder, Tachycardia, Troponin increased
Clinical narrative: *PCP Office triage note from 10/19/21 at 4pm: Patient was woken up at 4 am with chest pain, mid chest. Now c/o chest tightness, nausea and feels like vomiting- But dry heaving along with bloody nose from dry heaving. Denies SOB, pain traveling into arm, shoulder, ear, jaw, dizziness, cool moist skin, and blue lips. Advise to seek care @ ER- per protocol *Presented to the emergency department of Hospital on 10/19. Discharged 10/20.  Hospital note impression:  "-Acute myopericarditis. Likely referable to to recent booster dose of Moderna vaccine. Expected clinical course would be resolution. Symptomatic treatment with anti-inflammatory agents is reasonable. Declining troponin resolution of chest pain are encouraging for recovery.  -Hypertensive disorder: I suspect the hypertension and tachycardia secondary to the underlying inflammatory condition will resolve. Plan:  1. Metoprolol succinate 25 mg daily: will likely discontinue at follow-up.  2. Ibuprofen 800 mg Q 8 H prn for recurrent chest pain 3. Return to clinic to see me in approximately 2 weeks with an echocardiogram the same day. "
Age: 32.0
Sex: U
Vaccine: COVID19, FLU4, HEPA, COVID19, FLU4
Symptoms: Asthenia, Blood calcium normal, Blood potassium decreased, Chills, Dizziness
Clinical narrative: Per hospital event reporting system " I received Hepatitis A vaccine, flu vaccine and COVID booster shot (Pfizer) on 10/9/21 after being informed there were no contraindications in taking all 3 at the same time by Employee. I worked my 12 hours shift as scheduled, just feeling lightheaded, sweats and chills. I took tylenol during my shift. My shift ended around 1930 and I drove home. As I was driving home, I started to feel shakiness and numbness and tingling all over that started in my midsection and radiated outwards into my extremities, head, face, neck, mouth, tongue and throat. I became aware that either my blood glucose level was low, or I was having an immune reaction from the vaccines. I got home and immediately thought I was going to pass out. I tried to eat but was unable to swallow crackers. At this point, I was afraid my airway is being compromised, so my wife called 911. I was brought to the ER and was there for about 6 hours (discharged at around 0130)."
Age: 32.0
Sex: U
Vaccine: COVID19, FLU4, HEPA, COVID19, FLU4
Symptoms: Dysphagia, Dysstasia, Headache, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Per hospital event reporting system " I received Hepatitis A vaccine, flu vaccine and COVID booster shot (Pfizer) on 10/9/21 after being informed there were no contraindications in taking all 3 at the same time by Employee. I worked my 12 hours shift as scheduled, just feeling lightheaded, sweats and chills. I took tylenol during my shift. My shift ended around 1930 and I drove home. As I was driving home, I started to feel shakiness and numbness and tingling all over that started in my midsection and radiated outwards into my extremities, head, face, neck, mouth, tongue and throat. I became aware that either my blood glucose level was low, or I was having an immune reaction from the vaccines. I got home and immediately thought I was going to pass out. I tried to eat but was unable to swallow crackers. At this point, I was afraid my airway is being compromised, so my wife called 911. I was brought to the ER and was there for about 6 hours (discharged at around 0130)."
Age: 32.0
Sex: U
Vaccine: COVID19, FLU4, HEPA, COVID19, FLU4
Symptoms: Nausea, Panic attack, Paraesthesia, Paraesthesia oral, Pharyngeal hypoaesthesia
Clinical narrative: Per hospital event reporting system " I received Hepatitis A vaccine, flu vaccine and COVID booster shot (Pfizer) on 10/9/21 after being informed there were no contraindications in taking all 3 at the same time by Employee. I worked my 12 hours shift as scheduled, just feeling lightheaded, sweats and chills. I took tylenol during my shift. My shift ended around 1930 and I drove home. As I was driving home, I started to feel shakiness and numbness and tingling all over that started in my midsection and radiated outwards into my extremities, head, face, neck, mouth, tongue and throat. I became aware that either my blood glucose level was low, or I was having an immune reaction from the vaccines. I got home and immediately thought I was going to pass out. I tried to eat but was unable to swallow crackers. At this point, I was afraid my airway is being compromised, so my wife called 911. I was brought to the ER and was there for about 6 hours (discharged at around 0130)."
Age: 32.0
Sex: U
Vaccine: COVID19, FLU4, HEPA, COVID19, FLU4
Symptoms: Pharyngeal paraesthesia, Presyncope, Tremor, White blood cell count increased
Clinical narrative: Per hospital event reporting system " I received Hepatitis A vaccine, flu vaccine and COVID booster shot (Pfizer) on 10/9/21 after being informed there were no contraindications in taking all 3 at the same time by Employee. I worked my 12 hours shift as scheduled, just feeling lightheaded, sweats and chills. I took tylenol during my shift. My shift ended around 1930 and I drove home. As I was driving home, I started to feel shakiness and numbness and tingling all over that started in my midsection and radiated outwards into my extremities, head, face, neck, mouth, tongue and throat. I became aware that either my blood glucose level was low, or I was having an immune reaction from the vaccines. I got home and immediately thought I was going to pass out. I tried to eat but was unable to swallow crackers. At this point, I was afraid my airway is being compromised, so my wife called 911. I was brought to the ER and was there for about 6 hours (discharged at around 0130)."
Age: 32.0
Sex: U
Vaccine: COVID19, FLU4, HEPA, COVID19, FLU4
Symptoms: Chills, Dizziness, Dysphagia, Hyperhidrosis, Hypoaesthesia
Clinical narrative: Per hospital event reporting system " I received Hepatitis A vaccine, flu vaccine and COVID booster shot (Pfizer) on 10/9/21 after being informed there were no contraindications in taking all 3 at the same time by Employee. I worked my 12 hours shift as scheduled, just feeling lightheaded, sweats and chills. I took tylenol during my shift. My shift ended around 1930 and I drove home. As I was driving home, I started to feel shakiness and numbness and tingling all over that started in my midsection and radiated outwards into my extremities, head, face, neck, mouth, tongue and throat. I became aware that either my blood glucose level was low, or I was having an immune reaction from the vaccines. I got home and immediately thought I was going to pass out. I tried to eat but was unable to swallow crackers. At this point, I was afraid my airway is being compromised, so my wife called 911. I was brought to the ER and was there for about 6 hours (discharged at around 0130)."
Age: 32.0
Sex: U
Vaccine: COVID19, FLU4, HEPA, COVID19, FLU4
Symptoms: Immunodeficiency, Paraesthesia, Tremor
Clinical narrative: Per hospital event reporting system " I received Hepatitis A vaccine, flu vaccine and COVID booster shot (Pfizer) on 10/9/21 after being informed there were no contraindications in taking all 3 at the same time by Employee. I worked my 12 hours shift as scheduled, just feeling lightheaded, sweats and chills. I took tylenol during my shift. My shift ended around 1930 and I drove home. As I was driving home, I started to feel shakiness and numbness and tingling all over that started in my midsection and radiated outwards into my extremities, head, face, neck, mouth, tongue and throat. I became aware that either my blood glucose level was low, or I was having an immune reaction from the vaccines. I got home and immediately thought I was going to pass out. I tried to eat but was unable to swallow crackers. At this point, I was afraid my airway is being compromised, so my wife called 911. I was brought to the ER and was there for about 6 hours (discharged at around 0130)."
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immunisation, Off label use, Pulmonary embolism
Clinical narrative: Experienced coagulation after first two shots; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient that: A non-pregnant female patient of an unspecified age received first dose bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at single dose for COVID immunization and received second dose of bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at single dose for COVID immunization. The patient's medical history included type 1 diabetes mellitus from an unknown date and unknown if ongoing. Concomitant medications included insulin (INSULIN) taken for type 1 diabetes mellitus, start and stop date were not reported. If patient received any other vaccine in four weeks was reported as unknown and other medications in two weeks was type one diabetic-insulin. It was unknown if the patient was COVID prior vaccination and post vaccination. The patient experienced coagulation after first two shots and experienced pulmonary embolism with booster dose. The patient was in the hospital intubated at the time of report. Adverse event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care, hospitalization and life threatening illness (immediate risk of death from the event). The patient was hospitalised for 5 days. The patient received treatment for the event. The patient after first two IV (intravenous treatment), had booster in hospital and intubated. The clinical outcome of events was reported as recovering.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Coagulopathy
Clinical narrative: Experienced coagulation after first two shots; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient that: A non-pregnant female patient of an unspecified age received first dose bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at single dose for COVID immunization and received second dose of bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at single dose for COVID immunization. The patient's medical history included type 1 diabetes mellitus from an unknown date and unknown if ongoing. Concomitant medications included insulin (INSULIN) taken for type 1 diabetes mellitus, start and stop date were not reported. If patient received any other vaccine in four weeks was reported as unknown and other medications in two weeks was type one diabetic-insulin. It was unknown if the patient was COVID prior vaccination and post vaccination. The patient experienced coagulation after first two shots and experienced pulmonary embolism with booster dose. The patient was in the hospital intubated at the time of report. Adverse event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care, hospitalization and life threatening illness (immediate risk of death from the event). The patient was hospitalised for 5 days. The patient received treatment for the event. The patient after first two IV (intravenous treatment), had booster in hospital and intubated. The clinical outcome of events was reported as recovering.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Arthropathy, Blood test, Hypoaesthesia, Magnetic resonance imaging head
Clinical narrative: convulsions; Tremor/ shakiness; crippled hands; tightness in the mid-section; a foggy head; wheelchair bound; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer sponsored Program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, on 2021, as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  On an unspecified date in 2021, the patient experienced convulsions, tremors, shakiness, crippled hands, tightness in the mid-section, a foggy head, and was wheelchair bound. The outcome of the events was unknown at time of report. The patient stated that events directly related to her vaccination  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging spinal, Nerve conduction studies, Skin texture abnormal
Clinical narrative: convulsions; Tremor/ shakiness; crippled hands; tightness in the mid-section; a foggy head; wheelchair bound; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer sponsored Program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, on 2021, as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  On an unspecified date in 2021, the patient experienced convulsions, tremors, shakiness, crippled hands, tightness in the mid-section, a foggy head, and was wheelchair bound. The outcome of the events was unknown at time of report. The patient stated that events directly related to her vaccination  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Feeling abnormal, Limb injury, Seizure, Tremor
Clinical narrative: convulsions; Tremor/ shakiness; crippled hands; tightness in the mid-section; a foggy head; wheelchair bound; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer sponsored Program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, on 2021, as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  On an unspecified date in 2021, the patient experienced convulsions, tremors, shakiness, crippled hands, tightness in the mid-section, a foggy head, and was wheelchair bound. The outcome of the events was unknown at time of report. The patient stated that events directly related to her vaccination  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Wheelchair user
Clinical narrative: convulsions; Tremor/ shakiness; crippled hands; tightness in the mid-section; a foggy head; wheelchair bound; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer sponsored Program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, on 2021, as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  On an unspecified date in 2021, the patient experienced convulsions, tremors, shakiness, crippled hands, tightness in the mid-section, a foggy head, and was wheelchair bound. The outcome of the events was unknown at time of report. The patient stated that events directly related to her vaccination  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 10.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Dizziness, Syncope
Clinical narrative: @1230 pt washing hands in bathroom, Dad witnessed fainting, caught without fall. No LOC, no head trauma. Pt c/o "blackness" Dad brought pt to waiting area, immediately lay him across chairs. Checked response. AOx4, quiet tachy. SaO2 decrease. Pupil 4mm bilat. Transferred to gurney and brought to First Aid tent. 1st BP 85/55 to 90/58 to 90/60. Feet elevated for 10 mins in Trendelenburg. No thermometer available. Juice offered, total 350 juice.